Literature DB >> 18226517

Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention.

R Douglas Bruce1, Rebecca A Schleifer.   

Abstract

Opioid dependence is a complex medical condition affecting neurocognitive and physical functioning. Forced or abrupt opioid withdrawal may cause profound physical and psychological suffering, including nausea, vomiting, diarrhoea, extreme agitation and/or anxiety. Opioid-dependent individuals are especially vulnerable at the time of arrest or initial detention, when they may, as a result of their chemical dependency, be coerced into providing incriminating testimony, or be driven to engage in risky behaviour (such as sharing needles in detention) in order to avoid painful withdrawal symptoms. Upon incarceration, many opioid-dependent prisoners are forced to undergo abrupt opioid withdrawal (both from legally prescribed agonist therapy such as methadone as well as illicit opioids). Physical and psychological symptoms attendant to withdrawal may impair capacity to make informed legal decisions, and cause prisoners to risk HIV and other blood-borne diseases by sharing injection equipment. Although prisons must provide at least the standard of care to prisoners that is available in the general population, medication-assisted treatment, endorsed by international health and drug agencies as an integral part of HIV prevention and care strategies for opioid-dependent drug users, is unavailable to most prisoners. Medication-assisted treatment is a well-studied and validated pharmacological therapy for the medical condition known as opioid dependence. The failure to ensure prisoner access to this medical therapy threatens fundamental human rights protections against cruel, inhuman or degrading treatment and rights to health and to life. It also poses serious ethical problems for health care providers, violating basic principles of beneficence and non-maleficence (i.e., do good/do no harm). Governments must take immediate action to ensure access to opioid substitution to prisoners to ensure fulfilment of ethical and human rights obligations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18226517      PMCID: PMC2366202          DOI: 10.1016/j.drugpo.2007.11.019

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  45 in total

1.  Incarceration and risk for HIV infection among injection drug users in Bangkok.

Authors:  Kachit Choopanya; Don C Des Jarlais; Suphak Vanichseni; Dwip Kitayaporn; Philip A Mock; Suwanee Raktham; Krit Hireanras; William L Heyward; Sathit Sujarita; Timothy D Mastro
Journal:  J Acquir Immune Defic Syndr       Date:  2002-01-01       Impact factor: 3.731

2.  Methadone maintenance expands inside federal prisons.

Authors:  Barbara Sibbald
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

3.  [Patterns of heroin consumption in a jail on the northern Mexican border: barriers to treatment access].

Authors:  Patricia Cravioto; María Elena Medina-Mora; Blanca de la Rosa; Fernando Galván; Roberto Tapia-Conyer
Journal:  Salud Publica Mex       Date:  2003 May-Jun

4.  Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison.

Authors:  Will Small; S Kain; Nancy Laliberte; Martin T Schechter; Michael V O'Shaughnessy; Patricia M Spittal
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

Review 5.  A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.

Authors:  Daniel M Forton; Joanna M Allsop; I Jane Cox; Gavin Hamilton; Keith Wesnes; Howard C Thomas; Simon D Taylor-Robinson
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

6.  Hepatitis C virus infection and neurocognitive function.

Authors:  M Soogoor; H S Lynn; S M Donfield; E Gomperts; T S Bell; E S Daar
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

7.  Behavioural change amongst drug injectors in Scottish prisons.

Authors:  D Shewan; M Gemmell; J B Davies
Journal:  Soc Sci Med       Date:  1994-12       Impact factor: 4.634

8.  Recent incarceration independently associated with syringe sharing by injection drug users.

Authors:  Evan Wood; Kathy Li; Will Small; Julio S Montaner; Martin T Schechter; Thomas Kerr
Journal:  Public Health Rep       Date:  2005 Mar-Apr       Impact factor: 2.792

Review 9.  Neurobiology of addictive behaviors and its relationship to methadone maintenance.

Authors:  B Stimmel; M J Kreek
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

Review 10.  Death attributed to methadone.

Authors:  S V Vormfelde; W Poser
Journal:  Pharmacopsychiatry       Date:  2001-11       Impact factor: 5.788

View more
  8 in total

1.  Harm reduction ethics: Acknowledging the values and beliefs behind our actions.

Authors:  Craig L Fry; Kaveh Khoshnood; Robert Power; Mukta Sharma
Journal:  Int J Drug Policy       Date:  2008-01-16

2.  Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour.

Authors:  Jacob M Izenberg; Chethan Bachireddy; Jeffrey A Wickersham; Michael Soule; Tetiana Kiriazova; Sergii Dvoriak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2014-02-28

3.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Authors:  Jeannia J Fu; Nickolas D Zaller; Michael A Yokell; Alexander R Bazazi; Josiah D Rich
Journal:  J Subst Abuse Treat       Date:  2013-02-22

4.  A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kevin E O'Grady; Terrence T Fitzgerald; Frank J Vocci
Journal:  Drug Alcohol Depend       Date:  2017-01-11       Impact factor: 4.492

Review 5.  Public health and the epidemic of incarceration.

Authors:  Dora M Dumont; Brad Brockmann; Samuel Dickman; Nicole Alexander; Josiah D Rich
Journal:  Annu Rev Public Health       Date:  2012-01-03       Impact factor: 21.981

6.  "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.

Authors:  Jeronimo A Maradiaga; Shadi Nahvi; Chinazo O Cunningham; Jennifer Sanchez; Aaron D Fox
Journal:  J Subst Abuse Treat       Date:  2015-11-25

7.  High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes.

Authors:  Jacob M Izenberg; Chethan Bachireddy; Michael Soule; Tetiana Kiriazova; Sergey Dvoryak; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2013-06-12       Impact factor: 4.492

8.  How Drug Control Policy and Practice Undermine Access to Controlled Medicines.

Authors:  Naomi Burke-Shyne; Joanne Csete; Duncan Wilson; Edward Fox; Daniel Wolfe; Jennifer J K Rasanathan
Journal:  Health Hum Rights       Date:  2017-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.